Figure 7
From: Ovarian cancer treatment with a tumor-targeting and gene expression-controllable lipoplex
The typical distribution of tumor nodules and serologic biochemical analyses.
a for images (scale bars = 0.5 centimeter) and b for the graphs (mean ± SD, n = 4–6, *P < 0.05, **P < 0.01, ***P < 0.001, NS versus normal mice, LP/pVax, F-LP/pVax, F-LP/pMP(1), LP/pMP(2.5) and F-LP/pMP(2.5); #P < 0.05, ##P < 0.01, normal mice versus LP/pVax, F-LP/pVax, F-LP/pMP(1), LP/pMP(2.5) and F-LP/pMP(2.5)). ALT, alanine aminotransferase; ALP, alkaline phosphatase; TBil, total bilirubin; ALB, albumin; GLU, glucose; TP, total protein; CREA, creatinine; UREA, urea; UA, uric acid; TG, triglycerides; TC, total cholesterol; HDL, high-density lipoprotein-cholesterol; LDL, low-density lipoprotein-cholesterol. The horizontal lines indicate the reference range for each analyte. The reference ranges for ALT, ALP and TBil were 27–90 U/L, 57–160 U/L and 0.2–0.7 mg/dL, respectively. The reference ranges for ALB, GLU, TP, CREA, UREA and UA were 30–43 g/L, 7.38–13.44 mmol/L, 53–68 g/L, < 44.2 μmol/L, 6.07–16.07 mmol/L and <54.13 μmol/L, respectively. The reference ranges for TG, TC, HDL and LDL were 1.00–4.55 mmol/L, 1.81–5.12 mg/dL, >0.78 mmol/L and <1.35 mmol/L, respectively.
